Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK0557 in Obese Patients
NCT00092872Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Nov 2003
- Primary completion
- Feb 2005
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of MK-0557 in obesity, sponsored by Merck & Co.. Started Nov 2003; status: completed.
02
Drugs
MK-0557
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00092872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00092872.